Founded in March 2003 and based in Durham, North Carolina, HyperBranch is a privately-held medical device company, formed to develop biosurgical devices based on its proprietary polymers and their cross-linked hydrogels. Its initial focus is on the surgical sealant market to help reduce the morbidity and mortality of patients undergoing surgery.
HyperBranch scientists and engineers invented a family of unique polymers and cross linked hydrogels that are currently being developed into surgical sealants. HyperBranch's tunable hydrogels confer material properties of biocompatibility with superior tissue adherence, strength, and durability. Additionally, HyperBranch delivers its surgical sealants through easy to use, proprietary delivery devices designed with thoughtful input from leading medical professionals.
What we do?
HyperBranch Medical Technology, Inc. is a specialty medical device company that develops and markets products primarily for the traumatic or surgically induced wound market. We strive to provide superior benefits to professionals and patients through the development of novel products.
Our products are capable of adhering and sealing tissues to provide better clinical outcomes for the patient and surgeon. The technology on which our products are based is synthetic, safe, and highly configurable to meet the clinical requirements for a wide range of surgical procedures.
Commitment to Quality
HyperBranch is dedicated to delivering exceptional products and services that meet or exceed both internal and external customer requirements.